Signup Crypto ETF Stocks News

Bombardier to Showcase its Top Performing Global 7500 and Challenger 3500 Business Jets at the Catarina Aviation Show in Brazil

Bombardier's record-setting Global 7500 aircraft and best-selling Challenger 3500 aircraft will be on display at the Catarina Aviation Show in São Paulo, Brazil, highlighting their exceptional performance qualities, cutting-edge technology and innovative cabin designs

Source: www.benzinga.com
May 29, 2025 | 11:30:00
Category: News

Financial 15 Split Corp. Announces TSX Acceptance of Normal Course Issuer Bid

TORONTO, May 29, 2025 ( GLOBE NEWSWIRE ) -- Financial 15 Split Corp. ( the "Company" ) announced today that the Toronto Stock Exchange ( the "TSX" ) has accepted its notice of intention to make a Normal Course Issuer Bid ( the "NCIB" ) to purchase its Preferred Shares and Class A Shares through ...

Source: www.benzinga.com
May 29, 2025 | 11:30:00
Category: Markets

Canadian Banc Corp. Announces TSX Acceptance of Normal Course Issuer Bid

TORONTO, May 29, 2025 ( GLOBE NEWSWIRE ) -- Canadian Banc Corp. ( the "Company" ) announced today that the Toronto Stock Exchange ( the "TSX" ) has accepted its notice of intention to make a Normal Course Issuer Bid ( the "NCIB" ) to purchase its Preferred Shares and Class A Shares through the ...

Source: www.benzinga.com
May 29, 2025 | 11:30:00
Category: Markets

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

TORONTO, May 29, 2025 ( GLOBE NEWSWIRE ) -- Quantum BioPharma Ltd. ( NASDAQ: QNTM ) ( CSE: QNTM ) ( FRA: 0K91 ) ( "Quantum BioPharma" ) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that Unbuzzd Wellness Inc. ( formerly, ...

Source: www.globenewswire.com
May 29, 2025 | 11:30:00
Category: News

Vima Therapeutics Launches to Advance the First Oral Therapy for People with Dystonia and Related Movement Disorders

- $60 million Series A led by Atlas Venture, and founded by an expert team of physicians and scientists - VIM0423, a potential first-in-class oral medicine for isolated dystonia, is currently being studied in a Phase 1 clinical trial; Phase 2 planned for fourth quarter of 2025

Source: www.benzinga.com
May 29, 2025 | 11:30:00
Category: General

Dividend 15 Split Corp. II Announces TSX Acceptance of Normal Course Issuer Bid

TORONTO, May 29, 2025 ( GLOBE NEWSWIRE ) -- Dividend 15 Split Corp. II ( the "Company" ) announced today that the Toronto Stock Exchange ( the "TSX" ) has accepted its notice of intention to make a Normal Course Issuer Bid ( the "NCIB" ) to purchase its Preferred Shares and Class A Shares through ...

Source: www.globenewswire.com
May 29, 2025 | 11:30:00
Category: News

MariMed's Premium Nature's Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDose - MariMed ( OTC:MRMD )

NORWOOD, Mass., May 29, 2025 ( GLOBE NEWSWIRE ) -- MariMed Inc. ( "MariMed" ) MRMD MRMD, the company behind the award-winning flower and concentrate brand, Nature's Heritage™, continued to drive innovation with the launch of MycroDose by Nature's Heritage, a vegan line of all-natural wellness ...

Source: www.benzinga.com
May 29, 2025 | 11:30:00
Category: General

Apogee Therapeutics to Participate at the Jefferies Global Healthcare Conference

SAN FRANCISCO and BOSTON, May 29, 2025 ( GLOBE NEWSWIRE ) -- Apogee Therapeutics, Inc., ( Nasdaq: APGE ) , today announced that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 10:30 a.m. E.T.

Source: www.globenewswire.com
May 29, 2025 | 11:30:00
Category: News

Bombardier to Showcase its Top Performing Global 7500 and Challenger 3500 Business Jets at the Catarina Aviation Show in Brazil

MONTRÉAL, May 29, 2025 ( GLOBE NEWSWIRE ) -- Bombardier today announced that its record-setting Global 7500 and best-selling Challenger 3500 aircraft will be on display at the Catarina Aviation Show on June 5-7 in São Paulo, Brazil, revealing their uncompromising attributes for clients in the ...

Source: www.globenewswire.com
May 29, 2025 | 11:30:00
Category: News

Terrestrial Energy Announces Appointment of Brian Thrasher as Chief Financial Officer and Brian Romanzo as General Counsel - HCM II Acquisition ( NASDAQ:HOND )

Strategic hires bring decades of financial leadership, capital markets experience, and regulatory expertise to Terrestrial Energy's Executive Leadership Team in advance of anticipated transition to a publicly listed nuclear technology innovator company later this year

Source: www.benzinga.com
May 29, 2025 | 11:30:00
Category: News

© Natavest 2025 - 2026